VIM and ovarian carcinoma: Silencing of vimentin expression in A2780, HO-8910-PM and HO-8910 cells resulted in markedly increase the cell resistance to cisplatin further demonstrating that vimentin mediates drug resistance in ovarian cancer cells (Figure 2(f, i), Supplementary Figure S1f).